Research field (6):
Nutrition and health science
, Hematology and oncology
, Internal medicine - General
, Pathobiochemistry
, Cell biology
, Molecular biology
Research keywords (5):
Infectious disease epidemiology
, Hematology
, Cancer biology
, 腫瘍学
, 血液学
Research theme for competitive and other funds (5):
2016 - 2019 分子標的を用いた癌早期発見と癌二次予防の前臨床研究
2013 - 2016 分子標的を用いた癌早期診断と癌予防
2001 - 2002 アポトーシス核変化制御因子p74の作用機構と癌発生・進展への関与
2000 - 2001 アポトーシス細胞死の核変化を制御する新規カスパーゼ基質p74の作用機構
1999 - 2001 アポトーシス細胞死における核構造変化に関与する分子の同定
Papers (35):
Atsushi Takahashi. Factors contributing to the spread and convergence of SARS-CoV-2 infection in Japan. Journal of Kibi International University Research Institute of Health and Welfare. 2022. 22. 1-15
Toshio Hattori, Hiroko Iwasaki-Hozumi, Gaowa Bai, Haorile Chagan-Yasutan, Ashwnini Shete, Elizabeth Freda Telan, Atsushi Takahashi, Yugo Ashino, Takashi Matsuba. Both Full-Length and Protease-Cleaved Products of Osteopontin Are Elevated in Infectious Diseases. Biomedicines. 2021. 9. 8
Gaowa Bai, Daisuke Furushima, Toshiro Niki, Takashi Matsuba, Yosuke Maeda, Atsushi Takahashi, Toshio Hattori, Yugo Ashino. High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia. International Journal of Molecular Sciences. 2021. 22. 9. 4978-4978
Yasuhiko Kamikubo, Atsushi Takahashi. Epidemic trends of SARS-CoV-2 modulated by economic activity, ethnicity, and vaccination. Cambridge Open Engage. 2021
Yasuhiko Kamikubo, Toshio Hattori, Atsushi Takahashi. Epidemic trends of SARS-CoV-2 associated with immunity, race, and viral mutations. Cambridge Open Engate. 2020
Yasuki Hijikata, Toshihiko Okazaki, Yoshihiro Tanaka, Mutsunori Murahashi, Yuichi Yamada, Kazunari Yamada, Atsushi Takahashi, Hiroyuki Inoue, Junji Kishimoto, Yoichi Nakanishi, et al. A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors. PLoS ONE. 2018. 13. 1. e0187878
C. Sakamoto, H. Kohara, H. Inoue, M. Narusawa, Y. Ogawa, L. Hirose-Yotsuya, S. Miyamoto, Y. Matsumura, K. Yamada, A. Takahashi, et al. Therapeutic vaccination based on side population cells transduced by the granulocyte-macrophage colony-stimulating factor gene elicits potent antitumor immunity. CANCER GENE THERAPY. 2017. 24. 4. 165-174